vimarsana.com

Latest Breaking News On - Agenus inc - Page 6 : vimarsana.com

Small-Cap Cancer Drug Developer Agenus Highlights Encouraging Data From Colorectal Cancer, But Funding Concerns Loom - Agenus (NASDAQ:AGEN)

The latest Phase 1 trial results of Agenus' botensilimab and balstilimab (BOT/BAL) combination therapy for metastatic CRC showcase promising clinical activity.

William blairAgenus incBristol myers squibb coBiologics license applicationBristol myers squibb

Small-Cap Cancer Drug Developer Agenus Highlights Encouraging Data From Colorectal Cancer, But Funding Concerns Loom

Friday, Agenus Inc AGEN released updated results from its Phase 1 clinical trial of botensilimab and balstilimab (BOT/BAL) combination therapy for metastatic…

Agenus incReaking news

Updated Phase 1 Data Support Further Research of Botensilimab/Balstilimab in Refractory MSS CRC

Updated phase 1 findings with botensilimab/balstilimab in MSS/pMMR mCRC show that the regimen elicited respective 12- and 18-month OS rates of 71% and 62%.

United statesAgenus incColorectal cancer

Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday s Mid-Day Session

Shares of JPMorgan Chase & Co. (NYSE:JPM) fell sharply during Friday’s session following first-quarter earnings. Net revenue (managed).

Matt korandaZoetis incTechnologies ltdRunway incAdial pharmaceuticalsMarin software incorporatedPaxmedica incArista networks incIntrusion incSemiconductor holding incHanryu holdings incGraphjet technologyCaremax incDigital incAgenus incLyell immunopharma inc

RADCOM, Lotus Technology And 3 Stocks To Watch Heading Into Monday - Accenture (NYSE:ACN)

With U.S. stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows:

Ronen kannorHilik itmanLotus technology incBragg gaming group incAgenus incLotus technologyGuy shemeshChief financial officer ronenChief executive officer

vimarsana © 2020. All Rights Reserved.